Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Honma

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2005
[LIF (leukemia inhibitory factor)]Yoshio Honma
Leukemia & Lymphoma|August 3, 2002
Cotylenin A--a plant growth regulator as a differentiation-inducing agent against myeloid leukemiaYoshio Honma
Leukemia & Lymphoma|April 11, 2003
Differentiation of human myeloid leukemia cells by plant redifferentiation-inducing hormonesYoshio Honma, Yuki Ishii
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2010
[Leukemia inhibitory factor (LIF)]Koshi Kawakami, Yoshio Honma
Cancer Science|July 25, 2007
Therapeutic strategy using phenotypic modulation of cancer cells by differentiation-inducing agentsYoshio Honma, Miho Akimoto
Leukemia Research|August 23, 2002
Human B-cell lymphoma cell lines are highly sensitive to apoptosis induced by all-trans retinoic acid and interferon-gammaNozomi Niitsu, Masaaki Higashihara, Yoshio Honma
British Journal of Haematology|February 3, 2005
Induction of CCAAT/enhancer binding protein-delta by cytokinins, but not by retinoic acid, during granulocytic differentiation of human myeloid leukaemia cellsYuki Ishii, Takashi Kasukabe, Yoshio Honma
Biochimica Et Biophysica Acta|December 5, 2003
Cytokinin-induced differentiation of human myeloid leukemia HL-60 cells is associated with the formation of nucleotides, but not with incorporation into DNA or RNAYuki Ishii, Shingo Sakai, Yoshio Honma
Experimental Hematology|November 9, 2002
The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemiaNozomi Niitsu, Masaaki Higashihara, Yoshio Honma
Leukemia & Lymphoma|August 5, 2004
Granulocytic differentiation of leukemic cells with t(9;11)(p22;q23) induced by all-trans-retinoic acidKimiko Iijima, Yoshio Honma, Nozomi Niitsu
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2005
[LIF (leukemia inhibitory factor)]Yoshio Honma
Leukemia & Lymphoma|August 3, 2002
Cotylenin A--a plant growth regulator as a differentiation-inducing agent against myeloid leukemiaYoshio Honma
Leukemia & Lymphoma|April 11, 2003
Differentiation of human myeloid leukemia cells by plant redifferentiation-inducing hormonesYoshio Honma, Yuki Ishii
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2010
[Leukemia inhibitory factor (LIF)]Koshi Kawakami, Yoshio Honma
Cancer Science|July 25, 2007
Therapeutic strategy using phenotypic modulation of cancer cells by differentiation-inducing agentsYoshio Honma, Miho Akimoto
Leukemia Research|August 23, 2002
Human B-cell lymphoma cell lines are highly sensitive to apoptosis induced by all-trans retinoic acid and interferon-gammaNozomi Niitsu, Masaaki Higashihara, Yoshio Honma
British Journal of Haematology|February 3, 2005
Induction of CCAAT/enhancer binding protein-delta by cytokinins, but not by retinoic acid, during granulocytic differentiation of human myeloid leukaemia cellsYuki Ishii, Takashi Kasukabe, Yoshio Honma
Biochimica Et Biophysica Acta|December 5, 2003
Cytokinin-induced differentiation of human myeloid leukemia HL-60 cells is associated with the formation of nucleotides, but not with incorporation into DNA or RNAYuki Ishii, Shingo Sakai, Yoshio Honma
Experimental Hematology|November 9, 2002
The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemiaNozomi Niitsu, Masaaki Higashihara, Yoshio Honma
Leukemia & Lymphoma|August 5, 2004
Granulocytic differentiation of leukemic cells with t(9;11)(p22;q23) induced by all-trans-retinoic acidKimiko Iijima, Yoshio Honma, Nozomi Niitsu
Pageof 6